ERBB2 and breast carcinoma: It has also been observed that nuclear and cytoplasmic accumulation of β-catenin, which represents Wnt pathway activation, is more common in basal-like breast cancers, and a significant correlation was found between the aberrant expression of this maker and negativity of hormone receptors and HER2(Khramtsov et al., 2010).